XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Jun. 30, 2018
Cash flows from operating activities          
Net loss $ (37,494) $ (22,851) $ (73,667) $ (94,898)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization expense     1,606 1,700  
Non-cash interest expense     4,593 4,931  
Share-based compensation expense     18,663 13,538  
Loss on extinguishment and conversion of notes 0 0 0 (6,457)  
Realized gain or loss on investments, net     (36) 0  
Change in fair value of notes payable     65 200  
Changes in operating assets and liabilities:          
Accounts receivable     424 (12,879)  
Prepaid expenses and other assets     (41,525) (1,098)  
Accounts payable and other accrued expenses     (447) 4,291  
Accrued outsourcing costs     7,506 2,946  
Accrued compensation and benefits     882 173  
Deferred rent     (305) 134  
Deferred revenue     (4,881) (17,117)  
Other non-current liabilities     (304) 468  
Net cash used in operating activities     (87,426) (91,154)  
Cash flows from investing activities          
Purchases of property and equipment     (1,455) (1,122)  
Proceeds from investment     35 0  
Proceeds from investment     (390,146) (395,369)  
Purchases of marketable securities     306,978 138,241  
Net cash used in investing activities     (84,588) (258,250)  
Cash flows from financing activities          
Net proceeds from employee stock purchases and options exercised     12,600 18,274  
Payment of note payable     (15,000) 0  
Proceeds from the modification of long-term debt, net     33,776 0  
Payment for debt issuance costs     0 4,306  
Net cash provided by financing activities     153,902 297,326  
Net decrease in cash and cash equivalents     (18,112) (52,078)  
Cash and cash equivalents at beginning of period     114,748 125,933 $ 125,933
Cash and cash equivalents at end of period 96,636 73,855 96,636 73,855 $ 114,748
Supplemental disclosure of cash flow information          
Cash paid for interest     3,650 2,260  
Change in unrealized gain (loss) on marketable securities $ 274 $ (81) 626 (681)  
Follow on offering          
Cash flows from financing activities          
Net proceeds from the issuance of common stock     0 258,750  
Offering costs for issuance of common stock     0 (15,732)  
Market offering          
Cash flows from financing activities          
Net proceeds from the issuance of common stock     125,043 41,216  
Offering costs for issuance of common stock     $ (2,517) $ (876)